Re: 'Kakkos et al. Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'

dc.creator	Spanos, K.	en
dc.creator	Giannoukas, A. D.	en
dc.date.accessioned	2015-11-23T10:48:05Z
dc.date.available	2015-11-23T10:48:05Z
dc.date.issued	2015
dc.identifier	10.1016/j.ejvs.2014.11.019
dc.identifier.issn	1078-5884
dc.identifier.uri	http://hdl.handle.net/11615/33240
dc.source.uri	<Go to ISI>://WOS:000352332500022
dc.subject	COST-EFFECTIVENESS	en
dc.subject	WARFARIN	en
dc.subject	Surgery	en
dc.subject	Peripheral Vascular Disease	en
dc.title	Re: 'Kakkos et al. Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'	en
dc.type	journalArticle	en

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.